Federal contract award
140D0426C8136
PHARMACEUTICAL SERVICES
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of the Treasury |
| Office | ARC DIV PROC SVCS - AFRH |
| NAICS | 621399 — Offices of All Other Miscellaneous Health Practitioners |
| PSC | 3650 — Chemical and Pharmaceutical Products Manufacturing Machinery |
| Parent award / vehicle | Not reported |
| Set-aside | SMALL BUSINESS SET ASIDE - TOTAL |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $796.7K |
| Current contract value | $796.7K |
| Potential contract value / ceiling | $796.7K |
| Start date | Aug 14, 2024 |
| Current end date | Jun 30, 2026 |
| Potential end date | Jun 30, 2026 |
| Latest award activity | Jul 8, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 9 of 9 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 8, 2026 | ADMTRA | $0 | PHARMACEUTICAL SERVICES |
| Jul 8, 2026 | P00006 | $-75.8K | PHARMACEUTICAL SERVICES - MODIFICATION TO TRANSFER CONTRACT ADMINISTRATION AUTHORITY TO THE DEPARTMENT OF THE INTERIOR |
| Jul 8, 2026 | P0006A | $0 | PHARMACEUTICAL SERVICES |
| Feb 18, 2026 | P00005 | $228.0K | PHARMACEUTICAL SERVICES - OBLIGATE $228,000.00 |
| Sep 17, 2025 | P00004 | $-13.7K | PHARMACEUTICAL SERVICES - DE-OBLIGATE FUNDS. |
| Aug 8, 2025 | P00003 | $215.0K | PHARMACEUTICAL SERVICES - P00003 EXERCISE OPTION YEAR 1 |
| Jul 16, 2025 | P00002 | $47.0K | PHARMACEUTICAL SERVICES - P00002 OBLIGATE FUNDS ON CLIN 0007 AND DECREASE PLACEHOLDER CLIN 0008 |
| Apr 18, 2025 | P00001 | $73.0K | PHARMACEUTICAL SERVICES - P00001 INCREASE THE VALUE OF THE BASE YEAR, CANCEL OPTION YEAR 4 & CREATE PLACEHOLDER CLIN |
| May 2, 2024 | 0 | $323.2K | PHARMACEUTICAL SERVICES |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.